Search Results 801-810 of 17873 for Assay

  1. A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery - Mayo Clinic

    older than 6 weeks as documented by a local laboratory using standard assay methodology. - Non-emergent open chest cavity major cardiopulmonary bypass (CPB) ...

  2. Publications - Erik C. Thorland, Ph.D. - Mayo Clinic

    Clinical performance of the CytoScan Dx Assay in diagnosing ... A multiplex assay for the detection and mapping of complex glycerol kinase deficiency.

  3. Beating the beast: Mayo Clinic's pediatric urologists and their sarcoma team's mission to cure rhabdomyosarcoma

    Mayo Clinic investigators have developed a 3D microcancer assay, growing microtumors from patient tissue. By studying drug responses to these microtumors ...

  4. Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study - Mayo Clinic

    Endotoxin Activity Assay between ≥ 0.60 to <0.90 EA units. 7. Evidence of at least 1 of the following criteria for new onset organ dysfunction that is ...

  5. Study Evaluating ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Have MM positive for the t(11;14) translocation, as determined by an analytically validated fluorescence in situ hybridization (FISH) assay per the central ...

  6. A Study to Assess the Culture, PCR, Serology and Symptoms of COVID-19 - Mayo Clinic

    Consent waived. Topic 4 - Evaluation of plate-based and lateral flow serologic assays. Inclusion Criteria: For the plate-based assays: Clinical residuals ...

  7. Brain Tumor Program - Clinical trials

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  8. Estrogen Receptor Positive Breast Cancer Clinical Trials - Mayo Clinic Research

    Giving TTM may be effective in treating post-menopausal women with HER2-negative, ER-positive breast cancer undergoing surgery. DiviTum Biomarker Assay For ...

  9. Clinical trials - Oncology (Medical)

    ... assayed from blood of cases with CAP and controls without history of cancer. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL. Rochester, Minn., Scottsdale/Phoenix ...

  10. Brain Tumor Program - Clinical trials

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...